A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target for suppressing endothelial inflammation and atherosclerosis. Their work was published in Nature Cardiovascular Research.
A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target for suppressing endothelial inflammation and atherosclerosis. Their work was published in Nature Cardiovascular Research.
At Meditech Today, our mission is to illuminate, inform, and inspire our audience by delivering the most recent advancements and insights in medical technology.
We are dedicated to promoting innovation and progressing the frontiers of healthcare, envisioning a future where life is enriched and improved by cutting-edge medical solutions.
We believe in the potency of knowledge to spark innovation and propel development, making medical technology approachable and advantageous for everyone.
